Antimicrobial Resistance Phenotypic Profile of Isolates from Clinical Infections in Dogs

Ricardo Antonio Pilegi Sfaciotte, Lincoln Garcia Coronel, Alessandra Snak, Jéssica Tainá Bordin, Paula Wildemann, Fernanda Daniele Melo, Vanessa Kelly Capoia Vignoto, Sandra Maria Ferraz, Sheila Rezler Wosiacki, Sílvia Cristina Osaki


Background: Antimicrobial resistance is described as a condition in which a micro-organism is able to survive when exposed to an antimicrobial agent. The resistance rates to antimicrobials in companion animals have risen considerably. Studies of local antimicrobial susceptibility profiles are needed as well as education and warning about the use of tests for the identification and susceptibility of pathogenic bacterial strains. The aim of this study was to identify the main antimicrobial resistance in clinical samples of dogs, and to detect multidrug-resistant strains of importance to public health.

Materials, Methods & Results: Bacterial pathogens of 77 dog infections were isolated and their sensitivity profile to antimicrobials was determined. One hundred bacterial isolates were identified. Of these, 61 were Gram-positive (55 Staphylococcus spp., 4 Enterococcus spp. and 2 Streptococcus spp.) and 39 Gram-negative (36 fermenters and 3 non-fermenters). Seventy-nine isolates were considered multiresistant following individual assessment of drugs, and 85 following the evaluation of classes. Only 3 were sensitive to all drugs. Four isolates were resistant to all classes and only sensitive to some antibiotics. Of the 55 samples of Staphylococcus spp., 36 (65.45%) were identified as phenotypically MRS. Two isolates of Enterococcus spp. were resistant to vancomycin (VRE). Also 66.67% (26/39) of the samples were positive for the presumptive test for ESBL. For the MRS-positive isolates detected in this study, chloramphenicol was the antimicrobial that showed superior sensitivity in 74.29% of the cases (27/36); therefore it is considered the most appropriate for treatment of this type of micro-organism. In case of aminoglycosides, when their resistance was checked in MRS isolates, all resistance percentages increased, implying a limited use of this class for such a type of multi-resistant micro-organism. Contrarily, in case of ESBL, a superior sensitivity was observed towards MRS isolates, thus making them a prime treatment choice for the infection caused by these micro-organisms.

Discussion: Literature have reported a gradual increase in multidrug resistance towards antimicrobial agents in veterinary medicine over the past decades. In this study, 64% of multiresistant strains were considered of significant importance, notably MRS (36), VRE (2) and ESBL (26). The early identification of pathogens in animals has become an important step in order to minimize the transmission of antibacterial resistance. The increase in the number of multidrug-resistant bacteria in animals and humans demonstrates the need to develop and implement measures in order to monitor and control the spread of this resistance. It is possible that the increased drug resistance is linked to the constant exposure to these drugs and the subsequent selective pressure, causing the transfer of resistant genes between strains. Carbapenems and glycopeptides should be used with caution in veterinary medicine in order to prevent such processes of selection that develop resistance in micro-organisms to these two classes, which can result in cross-resistance between animals and humans and create obstacles in the treatment of patients, especially for the two drugs mentioned, since they are important for the treatment of nosocomial infections in humans. The resistance percentage towards fluoroquinolones was identified to be higher in Gram-positive isolates, particularly in MRS, which showed 75% resistance against this class (according to the CLSI, resistance to one fluoroquinolone antimicrobial agent provides resistance to other antimicrobials of this class). For ESBL isolates, the resistance was shown to be 50%. The resistance towards the fluoroquinolones and aminoglycosides class can be associated with the expression of the genes that produce ESBL.


ESBL; MRS; multidrug resistance; public health; VRE.

Full Text:



Anvisa. 2008. Manual de microbiologia clínica para o controle de infecção relacionada à assistência à saúde – Módulo 6: detecção e identificação e bactérias de importância médica. 2.ed. Brasília: Agência Nacional de Vigilância Sanitária, 150p. Disponível em: . [Accessed online in January 2017].

Arias M.V.B. & Carrilho C.M.D.M. 2012. Resistência antimicrobiana nos animais e no ser humano. Há motivo para preocupação? Semina: Ciências Agrárias. 33(2): 775-790.

Arias M.V.B., Batagllia L.A., Aiello G., Carvalho T.T. & Freitas J.C. 2008. Identificação da suscetibilidade antimicrobiana de bactérias isoladas de cães e gatos com feridas traumáticas contaminadas e infectadas. Semina: Ciências Agrárias. 29: 861-874.

Bannoehr J. & Guardabassi L. 2012. Staphylococcus pseudintermedius in the dog: taxonomy, diagnostics, ecology, epidemiology and pathogenicity. Veterinary Dermatology. 23: 25-3269.

Barie P.S. 2012. Multidrug-resistant organisms and antibiotic management. Surgical Clinics North America. 92(2): 345-391.

Bauer A.W., Kirby W.M.M., Sherris J.C & Turck M. 1966. Antibiotic susceptibility testing by a standardized single disk method. American Journal of Clinical Pathology. 45: 493-496.

Clinical and Laboratory Standards Institute - CLSI. 2015. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. 3rd edn. Wayne: CLSI, 117p.

Clinical and Laboratory Standards Institute - CLSI. 2017. Performance Standards for Antimicrobial Susceptibility Testing. CLSI Supplement M100. 27th edn. Wayne: CLSI, 282p.

Cohn L.A., Gary A.T., Fales W.H. & Madsen R.W. 2003. Trends in fluoroquinolone resistance of bacteria isolated from canine urinary tracts. Journal of Veterinary Diagnostic Investigation. 15: 338-343.

Coque T.M., Baquero F. & Canto N.R. 2008. Increasing prevalence of ESBL producing Enterobacteriaceae in Europe. Eurosurveill. 13: 19044.

Cruz A.R., Paes A.C. & Siqueira A.K. 2012. Perfil de sensibilidade de bactérias patogênica isoladas de cães frente a antimicrobianos. Revista Veterinária e Zootecnia. 19(4): 601-610.

Dal-Bó I.S., Ferrigno C.R.A., Ferreira M.P., Caquias D.F.I., Souza A.N.A., Rizzo M.F.C.I., Cavalcanti R.A.O. & Santos J.F. 2013. Infecção óssea após osteotomia para tratamento da ruptura de ligamento cruzado em cães. Acta ScientiaeVeterinariae. 41: 1148.

Dierikx C.M., Van Duijkeren E., Schoormans A.H., Van Essenzandbergen A., Veldman K. & Kant A. 2012. Occurrence and characteristics of extended-spectrum-beta-lactamase and AmpC-producing clinical isolates derived from companion animals and horses. Journal of Antimicrobial Chemotherapy. 67: 1368-1374.

Dipersio J.R. & Dipersio L.P. 2005. Update on the prevalence and spread of macrolide and lincosamide-resistant staphylococcal and streptococcal species. Reviews in Medical Microbiology. 16: 117-123.

EFSA & ECDC. 2015. EU Summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2013. European Food Safety Authority. 13: 1-178.

Eisner A., Feierl G., Gorkiewicz G., Dieber F., Kessler H.H., Marth E. & Köfer J. 2005. High prevalence of vanAtype vancomycin-resistant enterococci in Austrian poultry. Applied and Environmental Microbiology. 71: 6407-6409.

Guardabassi L. 2012. Veterinary hospital-acquired infections: The challenge of MRSA and other multidrug-resistant bacterial infections in veterinary medicine. The Veterinary Journal. 193: 307-308.

Ishii J.B., Freitas J.C. & Arias M.V.B. 2011. Resistência de bactérias isoladas de cães e gatos no Hospital Veterinário da Universidade Estadual de Londrina (2008-2009). Pesquisa Veterinária Brasileira. 31(6): 533-537.

Krumperman 1983. P.H. Multiple antibiotic resistance indexing of Escherichia coli to identify high-risk source of fecal contamination of foods. Applied Environmental Microbiology. 46(1): 165-170.

Lee J.H., Bae I.K. & Lee S.H. 2012. New definitions of extended-spectrum beta-lactamase conferring worldwide emerging antibiotic resistance. Medicinal Research Reviews. 32: 216-232.

Monchique C.R.O. 2013. Evolução da resistência aos antibióticos em Staphylococcus spp. - 1999 a 2006. 67f. Lisboa, Portugal. Dissertação (Mestrado em Medicina Veterinária) - Faculdade de Medicina Veterinária da Universidade de Lisboa.

Mota R.A., Fretias M.F.L., Porto W.J.N. & Silva L.B.G. 2005. Utilização indiscriminada de antimicrobianos e sua contribuição a multirresistência bacteriana. Brazilian Journal of Veterinary Research and Animal Science. 42(6): 465470.

Ngoi S.T. & Thong K.L. 2013. Molecular characterization showed limited genetic diversity among Salmonella Enteritidis isolated from humans and animals in Malaysia. Diagnostic Microbiology and Infectious Disease. 77: 304-311.

Pallo-Zimmerman L.M., Byron J.K. & Graves T.K. 2010. Fluoroquinolonas: Then and now. Compendium on Continuing Education for the Practicing Veterinarian. 32: E1-E8.

Pfeifer Y., Cullik A. & Witte W. 2010. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. International Journal of Medical Microbiology. 300: 371-379.

Sampaio I.B.M. 2010. Estatística Aplicada à Experimentação Animal. 3.ed. Belo Horizonte: FEPMVZ-Editora, 221p.

Sfaciotte R.A.P., Vignoto V.K.C. & Wosiacki S.R. 2014. Perfil de resistência antimicro-biana de isolados bacterianos de afecções clínicas do hospital veterinário da Universidade Estadual de Maringá. Revista de Ciência Veterinária e Saúde Pública. 1(1): 29-38.

Sfaciotte R.A.P., Coronel L.G., Osaki S.C. & Wosiacki S.R. 2015. Gram-positive bacterial resistant strains of interest in animal and public health. Semina: Ciências Agrárias. 36(4): 2693-2712.

Soares L.C., Pereira I.A., Coelho S.M.O., Cunha C.M.M., Oliveira D.F.B., Miranda A.N. & Souza M.M.S. 2008. Caracterização fenotípica da resistência a antimicrobianos e detecção do gene mecA em Staphylococcus spp. Coagulasenegativos isolados de amostras animais e humanas. Ciência Rural. 38(5): 1346-1350.

Sousa Junior M.A., Ferreira E.V. & Conceição G.C. 2004. Betalactamase de Espectro Estendido (ESBL): um importante mecanismo de resistência bacteriana e sua detecção no laboratório clínico. NewsLab. 63: 152-174.

Thomson K.S. 2010. Extended-spectrum β-lactamase, AmpC, and carbapenemase issues. Journal of Clinical Microbiology. 48: 1019-1025.


Copyright (c) 2018 Ricardo Antonio Pilegi Sfaciotte, Lincoln Garcia Coronel, Alessandra Snak, Jéssica Tainá Bordin, Paula Wildemann, Fernanda Daniele Melo, Vanessa Kelly Capoia Vignoto, Sandra Maria Ferraz, Sheila Rezler Wosiacki, Sílvia Cristina Osaki

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.